Additional License Clause Samples
The Additional License clause grants permission for the use of certain intellectual property or materials beyond the standard rights typically provided in an agreement. This clause may specify extra software modules, documentation, or proprietary technology that the licensee can access, often under defined conditions or for an added fee. Its core function is to clarify and formalize the scope of extended usage rights, preventing misunderstandings and ensuring both parties are aware of any supplementary permissions granted.
Additional License. Certain Software may be delivered with its own specific license (“Additional License”). In such a case, the terms of the Additional License will be delivered to State Purchaser, such as in a separate license .txt file or as part of a separate click-to-accept agreement, and will govern use of the Software by State Purchaser to the extent Contractor does not have a right to supersede them. Contractor’s licensors are third party beneficiaries of these license provisions (and those in the Master Agreement) with respect to their software and documentation.
Additional License. Upon the SGI Group's request, MIPS shall license to the SGI Group under commercially favorable terms, any MIPS Improvements or other MIPS technology or designs it makes available to its customers or third parties, not already licensed hereunder. MIPS shall deliver all such technology when MIPS makes such it generally available to MIPS customers and licensees or upon SGI's reasonable written request provided that SGI may make such request no more once in any six (6) month period. MIPS shall deliver the applicable changes to software source code and any reasonably available supporting documentation.
Additional License. To the extent Bayer wishes to obtain (a) a commercial license under any Know How or Patent Rights Controlled by Atara that is [[***]], or (b) [[***]] under Section 2.1.2, Bayer may, during the term of this Agreement, notify Atara of its desire to enter into negotiations regarding such potential license or expansion by providing written notice to Atara specifying (i) [[***]] or (ii) [[***]] license under the Know How granted to Bayer and its Affiliates under Section 2.1.2, as applicable. Upon Atara’s receipt of any such notice and if Atara so agrees in its sole discretion, the Parties shall discuss the terms of a possible license agreement with respect to the relevant intellectual property rights for which Bayer has requested a license.
Additional License. During the term of the paid License, the Licensee has the right to request the granting of the right to use the Service for additional users ("Additional License"). The amount of the additional license fee is set by the Price List valid at the time of granting the Additional License, unless otherwise agreed by the Parties. When calculating the license fee, an incomplete month of granting the License is taken as a full month. An additional license is granted to the Licensee subject to payment of an additional license fee within the terms and in the amount agreed by the Parties. If at the time of the request for an Additional License, the Licensee has a debt in paying the license fee, the Licensor has the right not to grant the Additional License to the Licensee until the Licensee fully repays the debt and pays the additional license fee.
Additional License. Employees required to be licensed and/or certified in more than one (1) legal jurisdiction because of job requirements will have the additional license and/or certification paid for by the Employer.
Additional License. Inovio hereby agrees to expand the license granted to Advaccine under Section 2.1 for Advaccine, by itself or through any of its Affiliates or a Third Party, to conduct the Phase 3 Clinical Trial in the Inovio Territory at Advaccine’s own cost and expense for the purpose of obtaining the Regulatory Approval of the Product in the Advaccine Territory, in the event of (i) unless a Phase 3 Clinical Trial in the Inovio Territory has already been completed, a Change of Control of Inovio, where the acquirer of Inovio, by itself or through any of its Affiliates or a Third Party, is developing, manufacturing or commercializing any Competing Product for the Advaccine Territory; (ii) an official request by any Regulatory Authority in the Advaccine Territory; (iii) the occurrence of such circumstances as described in Section 4.2; or (iv) otherwise upon mutual agreement of the Parties; provided, however, that Inovio shall have the right to review and approve the protocols and design of such Phase 3 Clinical Trial. Inovio hereby agrees to expand the license granted to Advaccine under Section 2.1 for Advaccine to have the Inovio Device Manufactured in the U.S. or any other mutually agreed upon country by a Third Party contract manufacturer for use with the Product in the Advaccine Territory in the event of the occurrence of an Insolvency Event of Inovio.
Additional License. Amgen is party to a License Agreement with The Texas A&M University System dated as of November 29, 1993 (the “Additional License”). If Amgen obtains the right under the Additional License to sublicense to Amylin Amgen’s rights under the current terms of the Additional License, the Parties will enter into an amendment to this Agreement to include the Licensed Patent (as defined in the Additional License) within the Other Licensed Patent Rights on terms consistent with the terms applicable hereunder to sublicensed rights and Other Licensed Patent Rights. Amgen will contact The Texas A&M University System to request the right to grant such sublicense, but Amgen shall have no liability for the failure to obtain the right to grant such sublicense.
Additional License. The Company and the Customer shall use commercially reasonable best efforts to enter into an agreement mutually agreeable thereto pursuant to which the scope of the License shall be amended to include UB-92 claims.
Additional License. Employees required to be licensed and/or certified in more than one (1) legal jurisdiction because of job requirements will have the additional license and/or certification paid for by the Employer. This requirement will not apply when the additional license/certification is needed because an employee elects to fill two (2) separate jobs in different jurisdictions. If an employee needs to obtain additional license because he/she bumps into a different jurisdiction (per the provisions of Article 2 and/or 19) or because an employee is required to transfer to a new jurisdiction as a result of restructuring, the Employer will pay the initial cost of the new license.
Additional License. Subject to DCC's performance of its obligations ------------------ hereunder, HP hereby grants to DCC and DCC hereby accepts during the Term, a worldwide, non-exclusive license under HP's copyright and trade secret rights in HP Technology to make, have made, use, sell and distribute any product incorporating, utilizing, or embodying, in whole or in part, HP Technology.